How Ph.D. was paid
$3.5M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Bonus | Stock | Options | Incentive | Other | Total |
|---|---|---|---|---|---|---|---|
| Jason Coloma, Ph.D.Chief Executive Officer | $629,167 | — | $2,367,000 | — | $457,600 | $4,500 | $3,458,267 |
| Harold Bernstein, M.D., Ph.D.President, Research and Development and Chief Medical Officer | $548,333 | — | $946,800 | — | $321,750 | $4,500 | $1,821,383 |
| Misbah TahirChief Financial Officer | $164,773 | $50,000 | — | $3,659,110 | $86,667 | $3,500 | $3,964,050 |
What changed and why
- $3.5MChief Executive Officer Jason Coloma received total compensation of $3,458,267 in fiscal year 2025, representing a decrease from the prior year total of $5,835,244.
- 130%Annual bonuses were determined based on corporate objectives, with the compensation committee approving an overall achievement level of 130% for 2025.
- $50,000Misbah Tahir was appointed Chief Financial Officer on September 2, 2025, receiving a signing bonus of $50,000 and option awards valued at $3,659,110.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.